Spectrum Pharmaceuticals logo

Spectrum Pharmaceuticals SPPI

report update icon

Quarterly report 2023-Q1
added 05-16-2026

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

Shares

183 M

Market Cap[1]

$ 189 M

EBITDA (LTM)

-

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
- 0.11 % $ 419 M Nasdaq Global Select Market usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
- -3.90 % $ 97.2 M Nasdaq Global Select Market chinaChina
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
MLND
- -5.36 % $ 20.2 M Nasdaq Global Select Market usaUSA
Intec Pharma Ltd Intec Pharma Ltd
NTEC
- -12.45 % $ 17.7 M Nasdaq Capital Market israelIsrael
Progenity, Inc. Progenity, Inc.
PROG
- -3.47 % $ 164 M Nasdaq Global Select Market usaUSA
Strongbridge Biopharma plc Strongbridge Biopharma plc
SBBP
- 1.52 % $ 136 M Nasdaq Global Select Market usaUSA
Seneca Biopharma, Inc. Seneca Biopharma, Inc.
SNCA
- -1.19 % $ 28.7 M Nasdaq Capital Market usaUSA
Celsion Corporation Celsion Corporation
CLSN
- -6.63 % $ 13.9 M Nasdaq Capital Market usaUSA
Генетико Генетико
GECO
- - - MOEX russiaRussia
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
- 0.74 % $ 768 M Nasdaq Capital Market israelIsrael
Abcam plc Abcam plc
ABCM
- - $ 4.9 B Nasdaq Global Select Market britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Affimed N.V. Affimed N.V.
AFMD
- -34.95 % $ 21.5 M Nasdaq Global Select Market,SPB germanyGermany
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
- -1.58 % $ 28.1 M Nasdaq Global Market chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
- - $ 12.5 M Nasdaq Global Market belgiumBelgium
Gracell Biotechnologies Gracell Biotechnologies
GRCL
- - $ 3.37 B Nasdaq Global Select Market chinaChina
Galapagos NV Galapagos NV
GLPG
- - $ 1.83 B Nasdaq Global Select Market belgiumBelgium
Teligent, Inc. Teligent, Inc.
TLGT
- -13.85 % $ 16.1 M Nasdaq Global Select Market usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
- - $ 2.91 B Nasdaq Global Select Market usaUSA
Aphria Inc. Aphria Inc.
APHA
- -0.45 % $ 4.87 B Nasdaq Global Select Market canadaCanada
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.
ARPO
- -0.90 % $ 104 M Nasdaq Capital Market usaUSA
Chiasma, Inc. Chiasma, Inc.
CHMA
- -6.00 % $ 238 M Nasdaq Global Select Market usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
- - $ 376 M Nasdaq Global Market usaUSA
Cellect Biotechnology Ltd. Cellect Biotechnology Ltd.
APOP
- 0.38 % $ 12.9 M Nasdaq Global Select Market israelIsrael
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
- 2.07 % $ 34.4 M Nasdaq Capital Market usaUSA
Cerecor Inc. Cerecor Inc.
CERC
- -1.68 % $ 283 M Nasdaq Capital Market usaUSA
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc.
CNST
- - $ 1.63 B Nasdaq Global Select Market usaUSA
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
- -1.77 % $ 39.2 M Nasdaq Capital Market bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
- 0.34 % $ 2.98 B Nasdaq Global Select Market,SPB usaUSA
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
- 1.3 % $ 27.7 M Nasdaq Global Select Market franceFrance
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
- - $ 6.81 B Nasdaq Global Select Market britainBritain
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
- - $ 1.7 B Nasdaq Global Select Market usaUSA
Liminal BioSciences Liminal BioSciences
LMNL
- - $ 256 M Nasdaq Global Market canadaCanada
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
- -2.54 % $ 57.2 M Nasdaq Global Market usaUSA
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
ODT
- -3.18 % $ 58.5 M Nasdaq Global Select Market usaUSA
Orphazyme A/S Orphazyme A/S
ORPH
- -2.25 % $ 31.3 M Nasdaq Global Select Market danmarkDanmark
Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc
OSMT
- -10.74 % $ 89.9 M Nasdaq Global Select Market usaUSA
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc.
PAND
- - $ 1.77 B Nasdaq Global Select Market usaUSA
Translate Bio, Inc. Translate Bio, Inc.
TBIO
- - $ 2.81 B Nasdaq Global Select Market,SPB usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
- - $ 1.94 B Nasdaq Capital Market canadaCanada
Urovant Sciences Ltd. Urovant Sciences Ltd.
UROV
- - $ 532 M Nasdaq Global Select Market britainBritain
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
- - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
- 0.52 % $ 821 M Nasdaq Global Select Market danmarkDanmark
Zogenix, Inc. Zogenix, Inc.
ZGNX
- -4.97 % $ 664 M Nasdaq Global Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.